TSHA Taysha Gene Therapies, Inc.
$4.20▼ -1.18%
Healthcare
Other
Volume 168.2K
Avg Volume (10D) 4.24M
Key Metrics & Fundamentals
Market Cap
$1.37B
P/E Ratio
–
Div Yield
0.00%
52W Range
3.46 - 7.30
% vs 50 MA
-14.06%
% vs 200 MA
-20.35%
RSI-14
46.9
MACD Histogram
+0.0700
Beta (1Y vs SPY)
1.84
Free Cash Flow
-$40.42M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$49.78M
COGS
–
Operating Exp
$50.78M
Operating Income
-$50.78M
EBIT
-$50.78M
Pretax Income
-$46.64M
Net Income
-$46.64M
EPS (Diluted)
-0.13
Price & Volume History
Loading chart…
Recent News
Does Early Rett Trial Success Change The Bull Case For Taysha Gene Therapies (TSHA)?
Simply Wall St. · Oct 18, 2026 10:07 PM ET
Taysha Gene Therapies (TSHA) Stock May Be Above Fair Value On Book Value
Simply Wall St. · Oct 9, 2026 2:12 PM ET
Taysha Gene Therapies (TSHA) Faces A Split Valuation Debate, Is It Really 66% Below Fair Value?
Simply Wall St. · Oct 9, 2026 3:15 AM ET
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Oct 2, 2026 8:00 AM ET
Taysha Gene Therapies Announces Multiple Encore Presentations Supporting TSHA-102 Rett Syndrome Clinical Program at the 55th Child Neurology Society Annual Meeting
GlobeNewswire · Oct 1, 2026 8:00 AM ET
Wolfe Research Initiates Taysha Gene Therapies at Outperform
MT Newswires · Sep 17, 2026 8:24 AM ET
These 3 Risky Stocks Could Be Sitting on 100% Upside
MarketBeat · Sep 7, 2026 11:35 AM ET
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 4, 2026 8:00 AM ET
Taysha Gene Therapies (TSHA) Q2 2026 Earnings Call
Motley Fool · Aug 18, 2026 7:13 PM ET
Taysha Gene Therapies (TSHA) After Rett Trial Progress And Catalent Expansion Is The Undervalued Case Stronger
Simply Wall St. · Aug 13, 2026 10:09 AM ET
Financial Overview - Income Statement
Quarterly
Dec 2025
See TSHA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.